The case for short-course chemotherapy of pulmonary tuberculosis

Short-course chemotherapy of pulmonary tuberculosis: a new approach to drug dosage in the initial intensive phase.

The American review of respiratory disease·1986

Progress in the second and third years of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate.

Bulletin of the World Health Organization·1961

Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of domiciliary chemotherapy, and influence of further chemotherapy on the relapse rate.

Bulletin of the World Health Organization·1961

Vepdegestrant: First Approval.

Drugs·2026

Non-invasive Assessment and Therapeutic Targeting in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Overcoming the Dissonance Between Drug Development and Precision Medicine.

Drugs·2026

Baxdrostat: First Approval.

Drugs·2026

Alopecia Areata: Current and Emerging Therapies.

Drugs·2026

Andamertinib: First Approval.

Drugs·2026

Cefepime/Zidebactam: First Approval.

Drugs·2026

One-pot dual-toehold RCA-Cas12a biosensor driven by a preassembled three-arm toehold-gated DNA template for sequence-selective miRNA liquid biopsy.

Biosensors & bioelectronics·2026

Non-bacterial Thrombotic Endocarditis in a Patient With Squamous Cell Carcinoma of the Lung: Diagnostic Challenges and Management Perspective.

Cureus·2026

The Great Mimickers: Navigating Diagnostic Pitfalls in Modern Rheumatology.

Cureus·2026

Surgical and Histopathologic Insights Into Mid-Aortic Syndrome: A Case Report.

Case reports in surgery·2026

Suspected Lamotrigine-Associated Haematological Adverse Reaction in the Context of Polypharmacy, Alcohol Use, HIV, and Recent Medication Changes.

Cureus·2026

Microsphazaphilones H-Y: new azaphilone pigments with HIV latency reversal activity from the marine-derived fungus Microsphaeropsis arundinis P1B.

Marine life science & technology·2026

Related Experiment Videos

The case for short-course chemotherapy of pulmonary tuberculosis

Related Concept Videos

Short-course chemotherapy of pulmonary tuberculosis: a new approach to drug dosage in the initial intensive phase.

Progress in the second and third years of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate.

Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of domiciliary chemotherapy, and influence of further chemotherapy on the relapse rate.

Vepdegestrant: First Approval.

Non-invasive Assessment and Therapeutic Targeting in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Overcoming the Dissonance Between Drug Development and Precision Medicine.

Baxdrostat: First Approval.

Alopecia Areata: Current and Emerging Therapies.

Andamertinib: First Approval.

Cefepime/Zidebactam: First Approval.

One-pot dual-toehold RCA-Cas12a biosensor driven by a preassembled three-arm toehold-gated DNA template for sequence-selective miRNA liquid biopsy.

Non-bacterial Thrombotic Endocarditis in a Patient With Squamous Cell Carcinoma of the Lung: Diagnostic Challenges and Management Perspective.

The Great Mimickers: Navigating Diagnostic Pitfalls in Modern Rheumatology.

Surgical and Histopathologic Insights Into Mid-Aortic Syndrome: A Case Report.

Suspected Lamotrigine-Associated Haematological Adverse Reaction in the Context of Polypharmacy, Alcohol Use, HIV, and Recent Medication Changes.

Microsphazaphilones H-Y: new azaphilone pigments with HIV latency reversal activity from the marine-derived fungus Microsphaeropsis arundinis P1B.

Related Experiment Videos

The case for short-course chemotherapy of pulmonary tuberculosis

Related Concept Videos

Related Articles